- Home
- HKPD vs EDSA Comparison
HKPD vs EDSA Comparison
Compare HKPD & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- EDSA
- Stock Information
- Founded
- HKPD 2016
- EDSA 2015
- Country
- HKPD Hong Kong
- EDSA Canada
- Employees
- HKPD N/A
- EDSA N/A
- Industry
- HKPD Other Pharmaceuticals
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- EDSA Health Care
- Exchange
- HKPD Nasdaq
- EDSA Nasdaq
- Market Cap
- HKPD 20.9M
- EDSA 17.5M
- IPO Year
- HKPD 2025
- EDSA N/A
- Fundamental
- Price
- HKPD $1.34
- EDSA $2.88
- Analyst Decision
- HKPD
- EDSA Strong Buy
- Analyst Count
- HKPD 0
- EDSA 2
- Target Price
- HKPD N/A
- EDSA $13.00
- AVG Volume (30 Days)
- HKPD 333.5K
- EDSA 110.6K
- Earning Date
- HKPD 08-14-2025
- EDSA 08-08-2025
- Dividend Yield
- HKPD N/A
- EDSA N/A
- EPS Growth
- HKPD N/A
- EDSA N/A
- EPS
- HKPD N/A
- EDSA N/A
- Revenue
- HKPD $20,313,818.00
- EDSA N/A
- Revenue This Year
- HKPD N/A
- EDSA N/A
- Revenue Next Year
- HKPD N/A
- EDSA N/A
- P/E Ratio
- HKPD N/A
- EDSA N/A
- Revenue Growth
- HKPD 21.72
- EDSA N/A
- 52 Week Low
- HKPD $0.81
- EDSA $1.55
- 52 Week High
- HKPD $3.79
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- HKPD 48.60
- EDSA 67.27
- Support Level
- HKPD $1.51
- EDSA $2.30
- Resistance Level
- HKPD $1.52
- EDSA $2.82
- Average True Range (ATR)
- HKPD 0.15
- EDSA 0.17
- MACD
- HKPD -0.02
- EDSA 0.03
- Stochastic Oscillator
- HKPD 23.81
- EDSA 100.00
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.